Detalles de la búsqueda
1.
Radial versus femoral access and bivalirudin versus unfractionated heparin in invasively managed patients with acute coronary syndrome (MATRIX): final 1-year results of a multicentre, randomised controlled trial.
Lancet
; 392(10150): 835-848, 2018 09 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-30153988
2.
Bivalirudin or Unfractionated Heparin in Acute Coronary Syndromes.
N Engl J Med
; 373(11): 997-1009, 2015 Sep 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-26324049
3.
Radial versus femoral access in patients with acute coronary syndromes with or without ST-segment elevation.
Eur Heart J
; 38(14): 1069-1080, 2017 04 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-28329389
4.
Radial versus femoral access in patients with acute coronary syndromes undergoing invasive management: a randomised multicentre trial.
Lancet
; 385(9986): 2465-76, 2015 Jun 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-25791214
5.
Randomized comparison of Zotarolimus-Eluting Endeavor Sprint versus bare-metal stent implantation in uncertain drug-eluting stent candidates: rationale, design, and characterization of the patient population for the Zotarolimus-eluting Endeavor Sprint stent in uncertain DES candidates study.
Am Heart J
; 166(5): 831-8, 2013 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-24176438
6.
A large, prospective, multicentre study of left main PCI using a latest-generation zotarolimus-eluting stent: the ROLEX study.
EuroIntervention
; 18(13): e1108-e1119, 2023 Feb 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-36043326
7.
Coronary calcification in patients presenting with acute coronary syndromes: insights from the MATRIX trial.
Eur Heart J Acute Cardiovasc Care
; 12(11): 782-791, 2023 Nov 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-37812760
8.
Sex-specific benefits of sirolimus-eluting stent on long-term outcomes in patients with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention: insights from the Multicenter Evaluation of Single High-Dose Bolus Tirofiban Versus Abciximab With Sirolimus-Eluting Stent or Bare-Metal Stent in Acute Myocardial Infarction Study trial.
Am Heart J
; 163(1): 104-11, 2012 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-22172443
9.
Importance and limits of pre-hospital electrocardiogram in patients with ST elevation myocardial infarction undergoing percutaneous coronary angioplasty.
Eur J Cardiovasc Prev Rehabil
; 18(3): 526-32, 2011 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-21450642
10.
Intensifying platelet inhibition with tirofiban in poor responders to aspirin, clopidogrel, or both agents undergoing elective coronary intervention: results from the double-blind, prospective, randomized Tailoring Treatment with Tirofiban in Patients Showing Resistance to Aspirin and/or Resistance to Clopidogrel study.
Circulation
; 119(25): 3215-22, 2009 Jun 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-19528337
11.
A rare but serious complication of ticagrelor therapy: a case report.
Eur Heart J Case Rep
; 4(5): 1-5, 2020 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-33204945
12.
Antiplatelet Therapy with Cangrelor in Patients Undergoing Surgery after Coronary Stent Implantation: A Real-World Bridging Protocol Experience.
TH Open
; 4(4): e437-e445, 2020 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-33376943
13.
Downstream or upstream administration of P2Y12 receptor blockers in non-ST elevated acute coronary syndromes: study protocol for a randomized controlled trial.
Trials
; 21(1): 966, 2020 Nov 24.
Artículo
en Inglés
| MEDLINE | ID: mdl-33234137
14.
Timing of Oral P2Y12 Inhibitor Administration in Patients With Non-ST-Segment Elevation Acute Coronary Syndrome.
J Am Coll Cardiol
; 76(21): 2450-2459, 2020 11 24.
Artículo
en Inglés
| MEDLINE | ID: mdl-32882390
15.
Emergency percutaneous coronary intervention in patients with ST-elevation myocardial infarction complicated by out-of-hospital cardiac arrest: early and medium-term outcome.
Am Heart J
; 157(3): 569-575.e1, 2009 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-19249431
16.
An Uncommon Case of Spontaneous Hemopericardium in a Patient Treated with Rivaroxaban.
J Cardiovasc Echogr
; 29(4): 180-182, 2019.
Artículo
en Inglés
| MEDLINE | ID: mdl-32090001
17.
Impact of angiographic coronary artery disease complexity on ischemic and bleeding risks and on the comparative effectiveness of zotarolimus-eluting vs. bare-metal stents in uncertain drug-eluting stent candidates.
Int J Cardiol
; 277: 60-65, 2019 Feb 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-30293666
18.
Comparison of angioplasty with infusion of tirofiban or abciximab and with implantation of sirolimus-eluting or uncoated stents for acute myocardial infarction: the MULTISTRATEGY randomized trial.
JAMA
; 299(15): 1788-99, 2008 Apr 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-18375998
19.
Bivalirudin or Heparin in Patients Undergoing Invasive Management of Acute Coronary Syndromes.
J Am Coll Cardiol
; 71(11): 1231-1242, 2018 03 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-29544607
20.
Two-by-two factorial comparison of high-bolus-dose tirofiban followed by standard infusion versus abciximab and sirolimus-eluting versus bare-metal stent implantation in patients with acute myocardial infarction: design and rationale for the MULTI-STRATEGY trial.
Am Heart J
; 154(1): 39-45, 2007 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-17584549